---
document_datetime: 2023-09-21 18:14:53
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/sprimeo-epar-all-authorised-presentations_en.pdf
document_name: sprimeo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 4.0664627
conversion_datetime: 2025-12-19 12:13:25.32599
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number                       | Invented name Strength   | Invented name Strength   | Pharmaceutical Form                   | Route of administration   | Packaging                                | Package size                      |
|---------------------------------|--------------------------|--------------------------|---------------------------------------|---------------------------|------------------------------------------|-----------------------------------|
| EU/1/07/407/001                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 7 tablets                         |
| EU/1/07/407/002                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 14 tablets                        |
| EU/1/07/407/003                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 28 tablets                        |
| EU/1/07/407/004                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC) authorised          | 30 tablets                        |
| EU/1/07/407/005                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 50 tablets                        |
| EU/1/07/407/006                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 56 tablets                        |
| EU/1/07/407/007                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 84 (3x28) tablets (multipack)     |
| EU/1/07/407/008                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 90 tablets                        |
| EU/1/07/407/009                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 98 (2x49) tablets (multipack)     |
| EU/1/07/407/010                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 280 (20x14) tablets (multipack)   |
| EU/1/07/407/011                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 7 tablets                         |
| EU/1/07/407/012                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 14 tablets                        |
| EU/1/07/407/013                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 28 tablets                        |
| EU/1/07/407/014                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use longer           | Blister (PA/Alu/PVC)                     | 30 tablets                        |
| EU/1/07/407/015                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 50 tablets                        |
| EU/1/07/407/016                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 56 tablets                        |
| EU/1/07/407/017                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 84 (3x28) tablets (multipack)     |
| EU/1/07/407/018                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 90 (3x30) tablets (multipack)     |
| EU/1/07/407/019                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PA/Alu/PVC)                     | 98 (2x49) tablets (multipack)     |
| EU/1/07/407/020                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use no               | Blister (PA/Alu/PVC)                     | 280 (20x14) tablets (multipack)   |
| EU/1/07/407/021                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PCTFE/PVC)                      | 14 tablets                        |
| EU/1/07/407/022                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PCTFE/PVC)                      | 28 tablets                        |
| EU/1/07/407/023                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PCTFE/PVC)                      | 30 tablets                        |
| EU/1/07/407/024                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PCTFE/PVC)                      | 50 tablets                        |
| EU/1/07/407/025                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PCTFE/PVC)                      | 56 tablets                        |
| EU/1/07/407/026                 | Sprimeo                  | 150 mg                   | Film-coated tablet product            | Oral use                  | Blister (PCTFE/PVC perforated unit-dose) | 56 x 1 tablets                    |
| EU/1/07/407/027                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PCTFE/PVC)                      | 90 tablets                        |
| EU/1/07/407/028                 | Sprimeo                  | 150 mg                   | Film-coated tablet Film-coated tablet | Oral use Oral use         | Blister (PCTFE/PVC)                      | 98 tablets                        |
| EU/1/07/407/029                 | Sprimeo                  | 150 mg Medicinal         |                                       |                           | Blister (PCTFE/PVC perforated unit-dose) | 98 (2 x 49 x 1) tablets           |
| EU/1/07/407/030                 | Sprimeo                  | 150 mg                   | Film-coated tablet                    | Oral use                  | Blister (PCTFE/PVC)                      | 280 (20 x 14) tablets (multipack) |
| EU/1/07/407/031 EU/1/07/407/032 | Sprimeo Sprimeo          | 300 mg 300 mg            | Film-coated tablet Film-coated tablet | Oral use Oral use         | Blister (PCTFE/PVC) Blister (PCTFE/PVC)  | 14 tablets 28 tablets             |
| EU/1/07/407/033                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PCTFE/PVC)                      | 30 tablets                        |
| EU/1/07/407/034                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PCTFE/PVC)                      | 50 tablets                        |
| EU/1/07/407/035                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PCTFE/PVC)                      | 56 tablets                        |
| EU/1/07/407/036                 | Sprimeo                  | 300 mg                   | Film-coated tablet                    | Oral use                  | Blister (PCTFE/PVC                       | 56 x 1 tablets                    |

<div style=\"page-break-after: always\"></div>

| EU/1/07/407/037 EU/1/07/407/038 EU/1/07/407/039   | Sprimeo Sprimeo Sprimeo   | 300 mg 300 mg 300 mg   | Film-coated tablet Film-coated tablet Film-coated tablet   | Oral use Oral use Oral   | Blister (PCTFE/PVC) Blister (PCTFE/PVC) Blister (PCTFE/PVC   | 90 tablets 98 tablets 98 (2 x 49 x 1) tablets   |
|---------------------------------------------------|---------------------------|------------------------|------------------------------------------------------------|--------------------------|--------------------------------------------------------------|-------------------------------------------------|
|                                                   |                           |                        |                                                            | use                      | perforated unit-dose)                                        |                                                 |
| EU/1/07/407/040                                   | Sprimeo                   | 300 mg                 | Film-coated tablet                                         | Oral use                 | Blister (PCTFE/PVC)                                          | 280 (20 x 14) tablets (multipack)               |

Medicinal product no longer authorised